Adial Pharmaceuticals
ADIL
#9854
Rank
NZ$11.51 M
Marketcap
$1.80
Share price
-7.50%
Change (1 day)
-50.04%
Change (1 year)

Revenue for Adial Pharmaceuticals (ADIL)

Revenue in 2024 (TTM): N/A

In 2022 the company made a revenue of N/A a decrease over the revenue in the year 2021 that were of N/A. The revenue is the total amount of income that a company generates by the sale of goods or services. Unlike with the earnings no expenses are subtracted.

Revenue history for Adial Pharmaceuticals from 2017 to 2024

Annual revenue

Year Revenue Change
2024 (TTM) N/A
2022 N/A
2021 N/A
2020 N/A
2019 N/A
2018 N/A
2017 N/A

Revenue for similar companies or competitors

Company Revenue Revenue differencediff. Country
NZ$0.24 BN/A๐Ÿ‡บ๐Ÿ‡ธ USA
N/AN/A Bahamas